Literature DB >> 20431855

The role of thrombin and protease-activated receptors in pain mechanisms.

Paul S García1, Amitabh Gulati, Jerrold H Levy.   

Abstract

As our knowledge of the mechanisms underlying the sensation of pain continues to expand, researchers are constantly searching for novel therapeutic targets. One such novel pain pathway involves thrombin and its associated protease-activated receptor (PAR). Besides its traditional role in haemostasis, thrombin has multiple roles in both the central and peripheral nervous system including activation of microglia, regulation of neuronal death and neurite outgrowth, and influencing the transmission of pain signals in the nociceptive circuitry. Eventually therapeutic modalities directed at these targets could provide novel therapeutic approaches for treating chronic pain. The thrombin-associated PARs also have roles in inflammation, neurodevelopment, and conducting pain, both in conjunction with thrombin and independently. Recent laboratory evidence suggests that the PARs can attenuate pain mediated by the enteric nervous system in animal models (for example in pancreatitis and colitis). This review highlights several pathways in the mediation of pain sensation that can be influenced by thrombin.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20431855     DOI: 10.1160/TH09-12-0848

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  9 in total

1.  The potential for salmon fibrin and thrombin to mitigate pain subsequent to cervical nerve root injury.

Authors:  Christine L Weisshaar; Jessamine P Winer; Benjamin B Guarino; Paul A Janmey; Beth A Winkelstein
Journal:  Biomaterials       Date:  2011-09-22       Impact factor: 12.479

2.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

3.  Capsaicin up-regulates protease-activated receptor-4 mRNA and protein in primary cultured dorsal root ganglion neurons.

Authors:  Dan Chen; Zhaojin Wang; Zaifeng Zhang; Rui Zhang; Lianfeng Yu
Journal:  Cell Mol Neurobiol       Date:  2012-12-30       Impact factor: 5.046

4.  Interleukin-1β increased the expression of protease-activated receptor 4 mRNA and protein in dorsal root ganglion neurons.

Authors:  Zhaojin Wang; Dan Chen; Rui Zhang; Shuhong An; Zaifeng Zhang; Qingyuan Ma
Journal:  Neurochem Res       Date:  2013-06-18       Impact factor: 3.996

5.  Ketorolac reduces spinal astrocytic activation and PAR1 expression associated with attenuation of pain after facet joint injury.

Authors:  Ling Dong; Jenell R Smith; Beth A Winkelstein
Journal:  J Neurotrauma       Date:  2013-05-06       Impact factor: 5.269

6.  Concentration-Dependent Dual Role of Thrombin in Protection of Cultured Rat Cortical Neurons.

Authors:  Paul S García; Vincent T Ciavatta; Jonathan A Fidler; Anna Woodbury; Jerrold H Levy; William R Tyor
Journal:  Neurochem Res       Date:  2015-09-05       Impact factor: 3.996

7.  Leech therapy for pain relief: Rational behind a notion.

Authors:  Mohsen Nouri; Kourosh Karimi-Yarandi; Farhad Etezadi; Abbas Amirjamshidi
Journal:  Surg Neurol Int       Date:  2012-12-26

8.  The serine protease inhibitor SerpinA3N attenuates neuropathic pain by inhibiting T cell-derived leukocyte elastase.

Authors:  Lucas Vicuña; David E Strochlic; Alban Latremoliere; Kiran Kumar Bali; Manuela Simonetti; Dewi Husainie; Sandra Prokosch; Priscilla Riva; Robert S Griffin; Christian Njoo; Stefanie Gehrig; Marcus A Mall; Bernd Arnold; Marshall Devor; Clifford J Woolf; Stephen D Liberles; Michael Costigan; Rohini Kuner
Journal:  Nat Med       Date:  2015-04-27       Impact factor: 53.440

9.  Salmon and human thrombin differentially regulate radicular pain, glial-induced inflammation and spinal neuronal excitability through protease-activated receptor-1.

Authors:  Jenell R Smith; Peter P Syre; Shaina A Oake; Kristen J Nicholson; Christine L Weisshaar; Katrina Cruz; Robert Bucki; Bethany C Baumann; Paul A Janmey; Beth A Winkelstein
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.